Bank of New York Mellon’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.4M Sell
2,892,536
-50,957
-2% -$1.18M 0.01% 828
2026
Q1
$60.5M Sell
2,943,493
-102,023
-3% -$2.3M 0.01% 883
2025
Q4
$72.2M Sell
3,045,516
-27,965
-0.9% -$681K 0.01% 803
2025
Q3
$76.5M Buy
3,073,481
+920,923
+43% +$19.8M 0.01% 775
2025
Q2
$49.5M Sell
2,152,558
-58,646
-3% -$1.36M 0.01% 1005
2025
Q1
$49.6M Sell
2,211,204
-148,646
-6% -$3.45M 0.01% 972
2024
Q4
$46.1M Sell
2,359,850
-227,357
-9% -$4.51M 0.01% 1074
2024
Q3
$47.1M Sell
2,587,207
-293,566
-10% -$5.6M 0.01% 1078
2024
Q2
$50.1M Sell
2,880,773
-594,571
-17% -$10.5M 0.01% 1033
2024
Q1
$68.1M Sell
3,475,344
-258,500
-7% -$5.46M 0.01% 867
2023
Q4
$86M Sell
3,733,844
-306,183
-8% -$6.85M 0.02% 722
2023
Q3
$92.9M Buy
4,040,027
+62,543
+2% +$1.59M 0.02% 636
2023
Q2
$104M Buy
3,977,484
+408,843
+11% +$10.8M 0.02% 608
2023
Q1
$98.5M Sell
3,568,641
-46,910
-1% -$1.24M 0.02% 625
2022
Q4
$82.1M Sell
3,615,551
-37,983
-1% -$1.06M 0.02% 699
2022
Q3
$124M Sell
3,653,534
-361,606
-9% -$13.4M 0.03% 509
2022
Q2
$117M Sell
4,015,140
-122,940
-3% -$3.13M 0.03% 553
2022
Q1
$111M Buy
4,138,080
+1,052,856
+34% +$24.9M 0.02% 626
2021
Q4
$79.8M Buy
3,085,224
+1,220,740
+65% +$30.4M 0.01% 833
2021
Q3
$43.9M Buy
1,864,484
+739,298
+66% +$25.8M 0.01% 1220
2021
Q2
$49.9M Buy
+1,125,186
New +$41.5M 0.01% 1139

Other funds holding PRVA

Bank of New York Mellon's PRVA Position: Q2 2026 in Review

Bank of New York Mellon reduced its Privia Health (PRVA) stake by 1.7% in Q2 2026, selling an estimated $1.18M and leaving 2,892,536 shares worth $74.4M. The position accounts for 0.01% of the portfolio, ranked #828.

Bank of New York Mellon first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $124M in Q3 2022. 124 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Bank of New York Mellon held 2,892,536 shares of Privia Health worth $74.4M as of Q2 2026.
  • Bank of New York Mellon sold 50,957 Privia Health shares in Q2 2026, an estimated $1.18M.
  • Privia Health made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #828 holding.
  • Bank of New York Mellon first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Bank of New York Mellon's Privia Health position peaked at $124M in Q3 2022.
  • 124 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.